Mounjaro and slow weight loss: what the evidence actually shows

What the trial data says about the pace of loss

The headline figure from SURMOUNT-1, published in the New England Journal of Medicine, is an average taken at 72 weeks. What it does not show is that weight came off steadily each week. In practice, participants experienced periods of faster loss, slower loss, and plateaus, all within a trial result that looks impressive as a final number. A six-week stretch with little movement on the scales is not grounds for alarm, and it is not unusual.

The titration schedule matters here. Treatment begins at 2.5mg, a dose whose primary job is helping the body settle rather than delivering therapeutic weight loss. Meaningful changes in appetite and weight typically emerge as the dose increases, which happens gradually over months. How Mounjaro affects weight over the full treatment course is shaped as much by this schedule as by the medicine itself. If you are still on a lower dose, slow progress is expected, not exceptional.

NICE's appraisal of tirzepatide (TA1026) notes that if less than 5% of body weight has been lost after six months at the highest tolerated dose, continuing treatment should be reviewed. That threshold is the clinical marker. It is not the right comparison for someone three or four months in and still titrating upward.

Why individual weight loss can slow down on Mounjaro even when everything looks right

Biology adapts. As body weight falls, the body's energy needs drop too, and the appetite suppression that felt dramatic in the first month becomes a new normal for the nervous system. This is not a flaw in the medicine, it is how the body responds to any sustained calorie deficit, and it has been observed across weight-loss interventions of all kinds.

Several practical factors also play a role. Protein intake tends to fall on a reduced appetite, which can accelerate muscle loss and lower metabolic rate. Sleep quality, chronic stress and certain concurrent medicines can each blunt response. Alcohol, even in moderate amounts, adds calories that a suppressed appetite does not always account for. One checking habit worth building: keep a rough food log for three or four days every few weeks. Not obsessively, just enough to notice whether protein and vegetables are still making it in alongside smaller overall portions.

A useful place to explore this further is our guide to why weight loss might slow on Mounjaro, which looks at specific causes in more detail. Separately, if you have noticed that your weight loss has slowed on Mounjaro and want to understand what that means for your progress, we cover that in its own dedicated guide. If you are asking whether progress slows naturally at later stages of treatment, that question has its own dedicated answer.

When slow progress signals something worth raising with a prescriber

There is a difference between a plateau that resolves after a few weeks and a sustained absence of progress over months. If you have been at or near your highest tolerated dose for several months and weight has not shifted at all, that deserves a clinical conversation. The prescriber can look at the full picture (other medicines, health conditions, the titration history) in a way a set of scales cannot.

Dose increases on a regulated programme like an existing Mounjaro treatment plan require clinical evidence before they are approved. That is a safeguard, not a barrier. Side effects can also dampen adherence in ways that compound slow progress: persistent nausea, for instance, sometimes leads people to under-eat in ways that accelerate muscle loss rather than fat loss. If that is happening, our page on what to do when Mounjaro weight loss has slowed down may help you decide whether it is worth raising with your prescriber. If that is happening, it is worth mentioning.

The NHS medicines information for tirzepatide covers what to expect and when to seek advice, it is a readable, trustworthy starting point between appointments. Slow weight loss on Mounjaro is common; it is rarely the end of the story. The prescribers at our clinical team review progress with every repeat order, so concerns about pace can be raised then or through aftercare at any point.

If you are weighing up whether to start treatment or exploring what is available, our free consultation is the right next step, a GPhC-registered prescriber reviews every application the same day it is submitted.